Mesenchymal Stem Cells and Their Potential as Therapeutics in Ischemic Heart Disease

newstemcellsource_1.pdf

Examination of the interaction of allogeneic MSCs with cells of the immune system indicates
little rejection by T cells.
Persistence of allogeneic MSCs in vivo suggests their potential “off the
shelf” therapeutic use for multiple recipients.

Umbilical cord blood stem cell transplants are less prone to rejection probably because
the cells have not yet developed the features that can be recognized and attacked by the recipient's immune system.
 Both the versatility and availability of these stem cells make them potent resources for transplant
therapies.

즉, 다른 사람의 줄기세포 중 MSCs은 우리 몸의 T세포에 의한 면역제거반응을 대부분 피해갈 수 있다는 것.
다른 사람의 MSCs가 몸속에서 계속 생존 가능하다...
엄청난 일 아닙니까.

다시 읽어 봅시다.

Persistence of allogeneic MSCs in vivo suggests their potential “off the
shelf” therapeutic use for multiple recipients.

 
태반, 양수,Umbilical cord나 젊은 사람등 싱싱한 MSCs를 늙고 병든 사람에게 투여하는 것이 가능하겠습니다.